Researchers have developed AI-designed intrabodies capable of functioning within human cells, offering potential new treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. These novel molecules are engineered to target specific cellular processes, opening avenues for therapeutic intervention previously inaccessible to conventional antibodies. This advancement represents a significant step in leveraging AI for the development of targeted cellular therapies. AI
IMPACT Enables targeted cellular therapies for neurodegenerative diseases, potentially revolutionizing treatment approaches.
RANK_REASON Research paper detailing a new AI-driven method for designing intrabodies.
Read on Mastodon — mastodon.social →
- Alzheimer's disease
- Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation
- Intrabodies targeting post-translational modifications of native proteins and method for obtaining them
- Parkinson's
AI-generated summary · Google Gemini · from 3 sources. How we write summaries →